SpacePharma has developed a portfolio of miniaturised, fully automated laboratory platforms that enable scientific research and manufacturing in microgravity. Built on microfluidics-based lab-on-a-chip technology, these systems are designed to conduct biological, biochemical and materials science experiments in space while reducing mission size, cost and operational complexity. The laboratories can operate across multiple microgravity environments, including parabolic flights, free-flying satellites, and the International Space Station (ISS). The microfluidic laboratory technology enables researchers to perform experiments and manufacturing processes in space that are difficult or impossible to achieve under Earth's gravitational conditions.
At the core of the company's technology is the autonomous lab-on-chip platform, which integrates fluid handling, optical imaging, spectroscopy, temperature regulation and remote operation into compact spacecraft-compatible payloads. The laboratories are designed to perform experiments without human intervention while allowing researchers to monitor experiments, collect data in real time and adjust operating parameters remotely during space missions.
SpacePharma's technology portfolio includes the SPAd-ISS, a 3U-6U laboratory developed for deployment aboard the International Space Station. The platform supports advanced biology and biochemistry experiments using multiple liquid channels, flow reactors, visible and fluorescence microscopy, spectrometry, and active temperature control. The company also offers SPmg, a compact 2U laboratory for free-orbit satellites and ISS missions that enables multiple autonomous experiments using a stirred micro-reactor, fluorescence microscopy, spectroscopy and integrated environmental monitoring systems.
For larger-scale research and future in-space production, SpacePharma is developing Spactory, a high-capacity automated laboratory designed for both scientific experimentation and manufacturing in orbit. The platform incorporates four production lines, dozens of flow reactors, advanced pumping systems, microscopy, spectrometry, multiple temperature zones and high-speed communications, enabling simultaneous experiments and scalable production aboard current and future crewed and uncrewed space platforms.
Supporting these laboratories is the company's proprietary Fluid Management System, which combines miniaturized syringe pumps, diaphragm pumps, multiplexed pumping technology and intelligent control electronics to provide precise, bubble-free liquid handling under microgravity conditions. Designed for harsh space environments, the system delivers accurate low-volume flow rates while maintaining temperature-controlled reservoirs for reliable experiment execution.
By combining autonomous laboratory platforms, microfluidic technologies, precision fluid management, remote operations, and scalable orbital manufacturing capabilities, SpacePharma provides an integrated infrastructure for conducting scientific research and future industrial production in space. Its technologies enable cost-effective access to microgravity while supporting applications across life sciences, biotechnology, advanced materials research and next-generation in-space manufacturing.
About SpacePharma
SpacePharma is a Swiss-Israeli space biotechnology company that develops autonomous laboratory technologies for conducting research and manufacturing in microgravity. The company designs miniaturized lab-on-chip platforms, orbital laboratory systems and fluid management technologies that operate aboard the International Space Station, nanosatellites and other space platforms. Through end-to-end mission planning, laboratory development and remote experiment management, SpacePharma enables scientific research and future in-space manufacturing across commercial, academic and government space programs.
Click here to learn more about SpacePharma's Space Technology
